MENINGOCOCCAL DISEASE CAN TAKE A LIFE IN 24 HOURS1-2
You can help prevent it with BEXSERO.3
Meningococcal disease, often referred to as meningitis, is an uncommon but serious infection.1,2,4 BEXSERO is now available free on the National Immunisation Schedule for children under 5 years of age 13-25 year olds who are entering within the next three months, or in their first year of specified close-living.5*
*For full funding criteria see Pharmaceutical Schedule
What is Meningococcal Disease?
Meningococcal disease, often referred to as meningitis, is an uncommon but serious infection. A person with meningococcal disease can develop meningitis, septicaemia (blood infection) or pneumonia. Early symptoms of meningococcal disease may appear mild — similar to those of a cold or the flu. However, symptoms can progress quickly.1,6
Who is at risk?
Anyone can get meningococcal disease — however, babies and children under 5 are at most risk, followed by teens and young adults.6
What is BEXSERO?
BEXSERO is a vaccine to help protect against meningococcal group B, the most common type of meningococcal disease in NZ. It is given by injection and the number of doses needed depends on the age of the person being vaccinated.3,4